Patent: 5,998,203
✉ Email this page to a colleague
Summary for Patent: 5,998,203
Title: | Enzymatic nucleic acids containing 5\'-and/or 3\'-cap structures |
Abstract: | An enzymatic nucleic acid molecule comprising a 5\'- and/or a 3\'-cap structure, wherein said structure is not a 5\'-5\'-linked inverted nucleotide or a 3\'-3\'-linked inverted nucleotide. |
Inventor(s): | Matulic-Adamic; Jasenka (Boulder, CO), Beigelman; Leonid (Longmont, CO), Karpeisky; Alexander (Boulder, CO), Jarvis; Thale (Boulder, CO), Usman; Nassim (Boulder, CO), DiRenzo; Anthony (Boulder, CO), Wincott; Francine (Longmont, CO) |
Assignee: | Ribozyme Pharmaceuticals, Inc. (Boulder, CO) |
Application Number: | 08/632,882 |
Patent Claims: | see list of patent claims |
Details for Patent 5,998,203
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2039-02-26 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2039-02-26 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2039-02-26 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |